The Opportunity
The Investment
Investment Terms
$100,000
$25,000 per company
Pre-seed (MVP or market-testing phase)
≤ $13M post-money
≤ $1M total raise
SAFE, Convertible Note, or Preferred Stock
Eligibility Requirements
Beyond Capital
More Than a Check
Access to Morgan's Network
Introductions to investors, enterprise leaders, and key stakeholders who can accelerate your growth.
Fundraising Support
Help getting your round in front of the right people. We know everybody—and we'll make sure they see your deck.
Blavity Ecosystem Access
Invitations to private gatherings, AfroTech events, and introductions to enterprise partners and chief diversity officers.
About the Investor
Meet Morgan DeBaun
Morgan DeBaun is the Founder and CEO of Blavity Inc., the largest media company for Black culture and millennials, and AfroTech, the leading platform for Black professionals in tech.
A serial entrepreneur and angel investor, Morgan has been recognized on Forbes 30 Under 30 and Inc.’s Female Founders 100. Her book, Rewrite the Rules, is a manifesto for entrepreneurs challenging the status quo.
This health tech investment initiative is part of Blavity’s broader expansion into health equity through Blavity Health and Health Stack—launching February 2026.
Inc. Female Founders 100
Questions
Frequently Asked Questions
US-based C Corporations with a woman or POC founder. You should be pre-product or have up to $250K in annualized revenue, with no previous equity raised above $250K. Your startup should be building health technology that serves underserved communities.
We're looking for pre-seed stage companies—typically those with an MVP or in the market-testing phase. If you're still building your first product or just starting to validate with customers, you're likely a good fit.
$25,000 per company, with a total of $100,000 allocated across this initiative.
We focus specifically on health technology. Consumer apps, fintech, and other sectors outside health tech are not eligible for this particular initiative.
Wearables focused on health outcomes, chronic disease management, or improving healthcare access for underserved communities are welcome to apply.
We invest at a valuation cap of $13M post-money or less.
Investments are made via SAFE, Convertible Note, or Preferred Stock—depending on your current round structure.
A pitch deck, brief description of your product and market, and basic company information. We've kept the application streamlined so you can focus on building.
We aim to review all applications within 2-3 weeks and will reach out to founders who move forward to the next stage.
This initiative is led by Morgan DeBaun and Blavity Inc., in partnership with ZEAL Capital Partners and Barclays.
Ready to Build the Future of Health Equity?
Applications are open. We want to hear from you.
Apply Now →